Have you lost the hybridoma for your key research antibody? Has batch-to-batch variability made your research irreproducible? Are engineering your antibodies into therapeutic candidates?
The Competitive Advantage of Protein Sequencing
Feb 12, 2020
Achieving research greatness and securing reproducibility